US Patent 11440914 Tricyclic amine compounds as CDK2 inhibitors
Patent 11440914 was granted and assigned to Incyte on September, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 30, 2020
Date of Patent
September 13, 2022
Patent Applicant
Patent Application Number
16863770
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11440914 Tricyclic amine compounds as CDK2 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
